» Articles » PMID: 19793761

Nodular Disease and Parafollicular C-cell Distribution: Results from a Prospective and Retrospective Clinico-pathological Study on the Thyroid Isthmus

Overview
Specialty Endocrinology
Date 2009 Oct 2
PMID 19793761
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The isthmus represents a peculiar, as yet partially unexplored, thyroid gland area.

Aim Of The Study: To assess i) the prevalence and clinico-pathological features of solitary thyroid isthmic nodules (STIN); ii) the frequency of medullary thyroid carcinoma (MTC) arising from the isthmus; and iii) the C-cell distribution in the isthmus of patients with MTC and benign nodular thyroid disease (NTD).

Subjects And Methods: Patients referred from 2006 to 2008 for STIN were prospectively recruited, and underwent serum calcitonin (C(t)) measurement and fine needle aspiration cytology (FNAC). MTCs diagnosed from 1993 to 2005 were retrospectively searched. Immunohistochemistry was performed using anti-C(t) antibodies on lateral lobes and isthmi of 50 benign NTD and 50 MTC cases.

Results: From 1993 to 2005, 150 patients underwent surgery for MTC. All patients had the neoplasm located in lateral thyroid lobes, none in the isthmus. In the 3 years following, 192 STIN patients (40 (21%) males, 152 (79%) females; mean age: 46.2+/-7.1 years; 6.4% of NTD subjects) were recruited. All had normal C(t) concentrations. FNAC was malignant or suspicious for malignancy in 14 (7.3%) patients. Histology found malignancy in 17 (9%) cases, MTC in none. C cells were disclosed in lateral thyroid lobes of 100% MTC and 77% benign NTD patients; isthmi were free of C cells in either group.

Conclusions: STINs are significantly less likely to be MTC in patients presenting with sporadic disease. Therefore, C(t) screening is not warranted in these subjects. Nonetheless, STINs are more likely to be neoplastic and deserve equal attention as those of the lateral lobes.

Citing Articles

Should there be a paradigm shift for the evaluation of isthmic thyroid nodules?.

Babayid Y, Gokcay Canpolat A, Elhan A, Ceyhan K, Corapcioglu D, Sahin M J Endocrinol Invest. 2024; 47(9):2225-2233.

PMID: 38366076 PMC: 11369056. DOI: 10.1007/s40618-024-02313-6.


Are clinicopathological features of the isthmic thyroid nodule different from nodules in thyroid lobes? A single center experience.

Dellal F, Topaloglu O, Baser H, Dirikoc A, Alkan A, Aksoy Altinboga A Arch Endocrinol Metab. 2021; 65(3):277-288.

PMID: 33844891 PMC: 10065331. DOI: 10.20945/2359-3997000000345.


Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.

Verbeek H, de Groot J, Sluiter W, Muller Kobold A, van den Heuvel E, Plukker J Cochrane Database Syst Rev. 2020; 3:CD010159.

PMID: 32176812 PMC: 7075519. DOI: 10.1002/14651858.CD010159.pub2.


New insight into ectopic thyroid glands between the neck and maxillofacial region from a 42-case study.

Gu T, Jiang B, Wang N, Xia F, Wang L, Gu A BMC Endocr Disord. 2015; 15:70.

PMID: 26581587 PMC: 4652437. DOI: 10.1186/s12902-015-0066-6.


Utility of serum thyroglobulin measurements after prophylactic thyroidectomy in patients with hereditary medullary thyroid cancer.

Seib C, Harari A, Conte F, Duh Q, Clark O, Gosnell J Surgery. 2014; 156(2):394-8.

PMID: 24882762 PMC: 4099273. DOI: 10.1016/j.surg.2014.03.037.